Company: FCRS
Filing Date: 2025-09-17
Form Type: S-1/A
Source: 0001213900-25-088487
Chunk: 3

Company: FutureCrest Acquisition Corp.
Filing Date: 2025-09-17
Form: S-1/A
Chunk 3
---
, if we seek shareholder approval of our initial business combination and we do not conduct redemptions in connection with our initial business combination pursuant to the tender offer rules, our amended and restated memorandum and articles of association provide that a public shareholder, together with any affiliate of such shareholder or any other person with whom such shareholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), will be restricted from redeeming its shares with respect to more than an aggregate of 15% of the shares sold in this offering without our prior consent. However, we would not be restricting our shareholders’ ability to vote all of their shares (including all shares held by those shareholders that hold more than 15% of the shares sold in this offering) for or against our initial business combination. See “Summary — The Offering — Limitation on redemption rights of shareholders holding 15% or more of the shares sold in this offering if we hold shareholder vote” on page 32 for further discussion on certain limitations on redemption rights. Our sponsor, FutureCrest Acquisition Sponsor LLC, and Cantor Fitzgerald & Co., the representative of the underwriters, have committed to purchase an aggregate of 3,500,000 private placement warrants (whether or not the underwriters’ over -allotmentoption is exercised in full), each exercisable to purchase one Class A ordinary share at $11.50 per share, at a price of $2.00 per warrant, or $7,000,000 in the aggregate, in a private placement that will close simultaneously with the closing of this offering. Of those 3,500,000 private placement warrants, our sponsor has agreed to purchase 2,250,000 warrants and Cantor Fitzgerald & Co. has agreed to purchase 1,250,000 warrants. Each private placement warrant is exercisable to purchase one Class A ordinary share at $11.50 per share.

Our sponsor has purchased an aggregate of 7,187,500Class B ordinary shares for an aggregate of $ 25,000, up to 937,500of which will be surrendered to us for no consideration after the closing of this offering depending on the extent to which the underwriters’ over -allotmentoption is exercised, which will automatically convert into Class A ordinary shares concurrently with or immediately following the consummation of our initial business combination, or earlier at the option of the holders thereof on a one -for-one